• 1
    Dawson KG, Emerson JC, Burns JL. Fifteen years of experience with bacterial meningitis. Pediatr Infec Dis J 1999; 18: 81622.
  • 2
    Deitzman DE, Fischer GW, Schoenknecht FD. Neonatal Escherichia coli septicemia: bacterial counts in blood. J Pediatr 1974; 85: 12830.
  • 3
    Grimwood K, Anderson P, Tan L, Nolan T. Twelve-year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child 2000; 83: 111116.
  • 4
    Jann K, Jann B. Polysaccharide antigens of Escherichia coli. Rev Infect Dis 1987; 5: S51726.
  • 5
    Vermeulen C, Cross A, Byrne WR, Zollinger W. Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli. Infect Immun 1988; 56: 272330.
  • 6
    Weiser JN, Gotschlich EC. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun 1991; 57: 22528.
  • 7
    Sim RB, Dodds AW. The Complement System: an introduction. In: Dodds, AW, Sim, RB, eds. Complement: a Practical Approach. Oxford: Oxford University Press, 1997: 117.
  • 8
    Ram S, Sharma AK, Simpson SD, Gulati S, McQuillen DP, Pangburn MK, Rice PA. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 1998; 187: 74352.
  • 9
    Thern A, Stenberg L, Dahlback B, Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4 BP), a regulatory component of the complement system. J Immunol 1995; 154: 375.
  • 10
    Johnsson E, Thern A, Dahlback B, Heden LO, Wikstrom M, Lindahl G. Human C4 BP binds to the hypervariable N-terminal region of many members in the streptococcal M protein family. Adv Exp Med Biol 1997; 418: 50510.
  • 11
    Perez-Caballero D, Alberti S, Vivanco F, Sanchez-Corral P, Rodriguez de Cordoba S. Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high-affinity group A Streptococcus binding site in FHL-1. Eur J Immunol 2000; 30: 124353.
  • 12
    Areschoug T, Stalhammar-Carlemalm M, Karlsson I, Lindahl G. Streptococcal beta protein has separate binding sites for human factor H and IgA-Fc. J Biol Chem 2002; 277: 126428.
  • 13
    Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC. A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J Immunol 2002; 169: 635260.
  • 14
    Prasadarao NV, Wass CA, Weiser JN, Stins MF, Huang SH, Kim KS. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun 1996; 64: 14351.
  • 15
    Bremer E, Silhavy TJ, Maldener M, Cole T. Isolation and characterization of mutants deleted for the sulA-ompA region of the E. coli K12 chromosome. FEMS Microbiol Lett 1986; 33: 1738.
  • 16
    Blom AM, Kask L, Dahlbäck B. CCP1-4 of the C4b-binding protein α-chain are required for factor I mediated cleavage of C3b. Mol Immunol 2003; 39: 54756.
  • 17
    Warren L. The thiobarbituric assay of sialic acid. J Biol Chem 1959; 234: 19715.
  • 18
    Roos A, Bouwman LH, Munoz J et al. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 2003; 39: 65568.
  • 19
    Ram S, Cullinane M, Blom AM et al. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med 2001; 193: 28195.
  • 20
    Pluschke G, Mercer A, Kusecek B, Pohl A, Achtman M. Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types. Infect Immun 1983; 39: 599608.
  • 21
    Berggard K, Johnsson E, Morfeldt E, Persson J, Stalhammar-Carlemalm M, Lindahl G. Binding of human C4 BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes. Mol Microbiol 2001; 42: 53951.
  • 22
    Nordstrom T, Blom AM, Forsgren A, Riesbeck K. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol 2004; 173: 4598606.
  • 23
    Jarva H, Ram S, Vogel U, Blom AM, Meri S. Binding of complement inhibitor to serogroup B Neisseria meningitides. J Immunol 2005; 174: 6299307.
  • 24
    Berggard K, Johnsson E, Mooi FR, Lindahl G. Bordetella pertussis binds the human complement regulator C4 BP. role of filamentous hemagglutinin. Infect Immun 1997; 65: 363843.
  • 25
    Meri T, Blom AM, Hartmann A, Lenk D, Meri S, Zipfel PF. The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect Immun 2004; 72: 663341.
  • 26
    Carlsson F, Berggard K, Stalhammar-Carlemalm M, Lindahl G. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J Exp Med 2003; 198: 105768.
  • 27
    Meri S, Pangburn MK. Discrimination between activators and non-activators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci USA 1990; 87: 39826.
  • 28
    Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8–11 of factor H. J Immunol 2002; 168: 188694.
  • 29
    Janulczyk R, Iannelli F, Sjoholm AG, Pozzi G, Bjorck L. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem 2000; 275: 3725763.
  • 30
    Kotarsky H, Gustafsson M, Svensson HG, Zipfel PF, Truedsson L, Sjobring U. Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding. Mol Microbiol 2001; 41: 81726.
  • 31
    Sukumaran SK, Shimada H, Prasadarao NV. Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A. Infect Immun 2003; 71: 595161.